Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-010441
Filing Date
2022-03-15
Accepted
2022-03-15 16:56:11
Documents
72
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K life-10k_20211231.htm   iXBRL 10-K 3246947
2 EX-10.20 life-ex1020_588.htm EX-10.20 178639
3 EX-14.1 life-ex141_7.htm EX-14.1 57913
4 EX-23.1 life-ex231_14.htm EX-23.1 5160
5 EX-31.1 life-ex311_13.htm EX-31.1 9817
6 EX-31.2 life-ex312_6.htm EX-31.2 9863
7 EX-32.1 life-ex321_11.htm EX-32.1 6019
8 EX-32.2 life-ex322_8.htm EX-32.2 6010
9 GRAPHIC gepyyp5b4qi1000001.jpg GRAPHIC 121087
  Complete submission text file 0001564590-22-010441.txt   11538553

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA life-20211231.xsd EX-101.SCH 60404
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20211231_cal.xml EX-101.CAL 59942
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20211231_def.xml EX-101.DEF 209571
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20211231_lab.xml EX-101.LAB 511899
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20211231_pre.xml EX-101.PRE 371190
66 EXTRACTED XBRL INSTANCE DOCUMENT life-10k_20211231_htm.xml XML 2199847
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37378 | Film No.: 22741955
SIC: 2836 Biological Products, (No Diagnostic Substances)